Dexmedetomidine Continuous Infusion for Refractory Cancer Pain at End of Life: A Case Report.

Byrne, Jennifer M; Mesarwi, Paula; Edmonds, Kyle P; Atayee, Rabia S

Byrne, Jennifer M; Mesarwi, Paula; Edmonds, Kyle P; Atayee, Rabia S.

J Pain Palliat Care Pharmacother ; 36(3): 200-206, 2022 Sep.

Article in En | MEDLINE | ID: mdl-35913091

Subject(s)

Cancer Pain; Dexmedetomidine; Neoplasms; Pain, Intractable; Analgesics, Opioid/therapeutic use; Cancer Pain/drug therapy; Death; Female; Humans; Middle Aged; Neoplasms/complications; Pain, Intractable/drug therapy; Pain, Intractable/etiology

Key words

Dexmedetomidine; EoL; palliative care unit; refractory pain

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pain, Intractable / Dexmedetomidine / Cancer Pain / Neoplasms Type of study: Etiology_studies / Guideline Limits: Female / Humans / Middle aged Language: En Journal: J Pain Palliat Care Pharmacother Journal subject: NEUROLOGIA / PSICOFISIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google